The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...

MG has unveiled the MG Cyberster and MG M9 under its luxury brand MG Select at the Bharat Mobility Global Expo 2025 in New Delhi, with pre-bookings now open. Listen to Story JSW MG Motor India has ...

The M9 positions MG in the premium electric MPV segment and will be offered exclusively through the brand's 'Select' dealerships MG to retail the premium M9 MPV via its new ‘Select’ dealerships.

On day 2, tocilizumab was administered ... including intramuscular epinephrine (0.5 mg) and intravenous dopamine (200 mg in 30 mL 0.9% NaCl, administered at 5 mL/h via micropump) to support blood ...

Amrita Krishnan, MD, discusses how data from ASH 2024 highlight the critical role of intravenous immunoglobulin (IVIG) treatment in preventing infections in patients receiving teclistamab, shares ...

The 41.9 kWh battery pack in Chevrolet Spark EUV spied testing, is rated to deliver around 400 km on a single charge (CLTC cycle) You might be familiar with the Yep 3-Door and Yep Plus 5-Door ...